Literature DB >> 15264873

99mTc-neolactosylated human serum albumin for imaging the hepatic asialoglycoprotein receptor.

Jae Min Jeong1, Mee Kyoung Hong, Jaetae Lee, Miwon Son, Young So, Dong Soo Lee, June-Key Chung, Myung Chul Lee.   

Abstract

99mTc-labeled diethylenetriaminepentaacetic acid (DTPA)-coupled neogalactosyl human serum albumin (GSA) is used as an imaging agent for asialoglycoprotein receptor of the liver. However, its labeling is inconvenient because it should be incubated for 30 min at 50 degrees C. In addition, the conjugated DTPAs can cause decrease of pI and denaturation of protein. Therefore, we developed an improved agent 99mTc-neolactosyl human serum albumin (LSA) which contains a terminal galactose. LSA was synthesized by conjugating lactose to human serum albumin by the formation of a Schiff's base and successive reduction with sodium cyanoborohydride. The number of conjugated lactose molecules per LSA was 40.7 +/- 12.3. To simplify the labeling procedure, we used a direct labeling method that adopts a high affinity 99mTc binding site concept in antibody labeling. The produced LSA was reduced by beta-mercaptoethanol to generate sulfhydryl groups and purified by PD-10 size-exclusion column. The number of generated sulfhydryl groups per LSA was 21.9 +/- 3.0. Medronate and stannous chloride were added to the reduced LSA and freeze-dried. Finally, 99mTc-pertechnetate (37 MBq, 1 mL) was added to the vial and incubated for 10 min at room temperature. The labeling efficiency of 99mTc-LSA was higher than 98%, and the stability in human serum at 37 degrees C for 24 h was over 90%. Biodistribution study using balb/c mice and imaging study using SD rats showed high initial liver uptake and slow increase in the intestine due to hepatobiliary excretion after metabolism in the hepatocytes. Negligible spleen uptake was found while 99mTc-tin colloid showed significant amount of spleen uptake due to reticuloendothelial uptake. In conclusion, an improved agent, 99mTc-LSA, for imaging asialoglycoprotein receptor of the liver was successfully developed which showed a simple labeling procedure, high labeling efficiency, high stability, and high initial liver uptake.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15264873     DOI: 10.1021/bc0342074

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  6 in total

Review 1.  KSNM60: The History of Radiopharmaceutical Sciences in Korea.

Authors:  Ran Ji Yoo; Yun-Sang Lee; Kyo Chul Lee; Dong Wook Kim; Dong-Yeon Kim; Yearn Seong Choe; Jae Min Jeong
Journal:  Nucl Med Mol Imaging       Date:  2022-04-05

2.  Towards in vivo imaging of cancer sialylation.

Authors:  Ivan Martinez-Duncker; Roberta Salinas-Marin; Carlos Martinez-Duncker
Journal:  Int J Mol Imaging       Date:  2011-09-19

3.  Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.

Authors:  Guilan Quan; Xin Pan; Zhouhua Wang; Qiaoli Wu; Ge Li; Linghui Dian; Bao Chen; Chuanbin Wu
Journal:  J Nanobiotechnology       Date:  2015-02-03       Impact factor: 10.435

4.  Imaging Hydrogen Sulfide in Hypoxic Tissue with [99mTc]Tc-Gluconate.

Authors:  Yongkyoung Kweon; Ji-Yong Park; Young-Joo Kim; Yun-Sang Lee; Jae-Min Jeong
Journal:  Molecules       Date:  2020-12-28       Impact factor: 4.411

5.  A Novel Copolymer-Based Functional SPECT/MR Imaging Agent for Asialoglycoprotein Receptor Targeting.

Authors:  Pu Zhang; Zhide Guo; Deliang Zhang; Chang Liu; Guibing Chen; Rongqiang Zhuang; Manli Song; Hua Wu; Xianzhong Zhang
Journal:  Mol Imaging       Date:  2016-12-09       Impact factor: 4.488

6.  Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting.

Authors:  Anders Myrhammar; Anzhelika Vorobyeva; Kristina Westerlund; Shuichiro Yoneoka; Anna Orlova; Takehiko Tsukahara; Vladimir Tolmachev; Amelie Eriksson Karlström; Mohamed Altai
Journal:  Sci Rep       Date:  2020-11-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.